Henry Schein (HSIC) Q4 FY25 earnings call: guidance and Q&A

How should the $125 million run rate operating income improvement be phased throughout 2026, and how much will flow through to the bottom line in 2027?

The benefits from value creation initiatives will not be linear, with earnings growth more heavily weighted to the second half of 2026 due to investments in the first half. The exact flow-through to 2027 is yet to be determined, depending on ongoing investments and business conditions.

“I do think that as we make investments in the first half of the year and continue to make some investments over the course of the year, that will be reflected in our results. But we've taken that into consideration with the guidance.”

asked by Jeff Johnson · answered by Ronald South

Can you elaborate on the strong growth in specialty products, particularly value and premium implants, and discuss pricing dynamics and how price growth will contribute in 2026?

Strong growth in Europe, particularly Germany, was noted, with value implants becoming a larger portfolio part. Pricing is considered well-positioned within the market, with no unusual price increases. The growth is attributed to a mix shift towards faster-growing brands and market share gains, rather than significant pricing changes.

“The issue is that there's been a movement, a mix within our portfolio towards the brands that Ron just identified. the Camlog brand in Germany, for example, which is our largest market for that product, has stable pricing, yet we continue to gain market share.”

asked by Allen Lutz · answered by Stanley Bergman

What is the durability of the improved dental market performance, especially regarding patient traffic, consumer spending on high-end categories, and dentist spending on equipment, and are there any unique Q4 factors that might not persist?

The U.S. dental market is stable, leaning positively, with good dentist sentiment for investing in technology. Patient traffic is stable to slightly positive. The improved performance is also due to Henry Schein's renewed aggressive market approach post-cyber incident, expanding the market within its customer base. No unique Q4 factors suggest the momentum won't persist.

“I would say the markets are stable. Certainly in the U.S., we have data from our Henry Schein One claims processing. So essentially, it is a stable market leading, I would say, positively.”

asked by Jason Bednar · answered by Stanley Bergman

Will the value creation initiatives result in a headwind early in the year, and will there still be a net benefit for the full year 2026?

The expectation is for a clear net benefit from the initiatives for the full year 2026. While there might be some lumpiness in quarterly results due to investment timing, the overall benefit will be more heavily weighted towards the second half of the year.

“Yes, John, I mean, the expectation for the full year is clearly that there will be a net benefit from the initiatives. Within the quarters, you could get some lumpiness depending on the timing of some of the investment.”

asked by John Stansel · answered by Ronald South

How much lower will remeasurement gains be in 2026 compared to 2025's $0.23, and was the double-digit traditional equipment growth in Q4 due to promotions, and is it sustainable?

Remeasurement gains are expected to be lower in 2026 than in 2025, but the exact amount is difficult to gauge due to potential transactions. Equipment growth was not due to massive promotions but normal year-end activity and specific manufacturer promotions for higher-priced, feature-rich products. The momentum is good, with strong order intake and backlog, suggesting sustainability driven by sales efforts and dentist confidence.

“But what we said is the EPS guidance assumes remeasurement gains will be lower in '26 than it was in '25. As you can appreciate, it's difficult to gauge sometimes what the benefit of these will be. But we do expect -- we're pretty confident it will be less than what we had in 2025.”

asked by Kevin Caliendo · answered by Ronald South

How are the core underlying margins of the business trending before considering remeasurement dynamics and operational benefits?

Margins are influenced by product mix dynamics, such as value implants growing faster than premium implants, which can slightly pressure gross margin percentage but drive gross profit dollar growth. Customer mix, including DSOs, also impacts margins. The focus is on expanding gross profit dollars and leveraging G&A initiatives to improve operating margins, with benefits expected in the second half of the year.

“I think that a lot of moving parts when it comes to margins because of the -- when you look at the business as a whole, we are experiencing some product mix dynamics, for example, within the Specialty group.”

asked by Michael Cherny · answered by Ronald South